Glucocorticoid receptor density correlates with health risk factors and insulin resistance in Caucasian and African American subjects

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 8, 2012, Pages 477-481

  Islam, A ^a   Chen, Y ^a   Poth, M ^a   Smith, Z P ^a   Deuster, P A ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

glucocorticoid receptor; insulin resistance; leukocyte

Indexed keywords

GLUCOCORTICOID RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY FAT; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HEALTH HAZARD; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RECEPTOR DENSITY; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPOSITY; ADOLESCENT; ADULT; AFRICAN AMERICANS; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN RESISTANCE; LEUKOCYTES; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84866420939     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1321809     Document Type: Article

References (32)

1. Strain G W, Zumoff B, Kream J et al. Sex difference in the influence of obesity on the 24h mean plasma concentration of cortisol. Metabolism: 1982; 31 209 212 (Pubitemid 12176906)
2. Reul JMH M, de Kloet E R. Two receptor systems for corticosterone in rat brain: micro-distribution and differential occupation. Endocrinology: 1985; 117 2505 2511 (Pubitemid 16194083)
3. Dallman M F, Akana S F, Cascio C S et al. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res: 1987; 43 113
4. Meaney M J, Dioro J, Francis D et al. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Dev Neurosci: 1996; 18 49 72 (Pubitemid 26257908)
5. Garlow S J, Ciaranello R D. Transcriptional control of the rat serotonin-2 receptor gene. Mol Brain Res: 1995; 31 201 209
6. Pelaia G, Vatrella A, Cuda G et al. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sciences: 2003; 72 1549 1561 (Pubitemid 36120783)
7. Labeur M, Holsboer F. Molecular mechanisms of glucocorticoid receptor signaling. Medicina: 2010; 70 457 462
8. Jessop D S, Dallman M F, Fleming D et al. Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab: 2001; 86 4109 4114 (Pubitemid 32848521)
9. Ashwell J D, Lu F W, Vacchio M S. Glucocorticoids in T cell development and function. Annu Rev Immunol: 2000; 18 309 345 (Pubitemid 30365383)
10. Cooper M S, Stewart P M. 11β-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. J Clin Endocrinol Metab: 2009; 94 4645 4654
11. Siegel J M, Hyg M S, Yancey A K et al. Overweight and depressive symptoms among African-American women. Preventive medicine: 2000; 31 232 240
12. Frazier B, Hsiao C W, Deuster P A et al. African Americans and Caucasian Americans: differences in glucocorticoid-induced insulin resistance. Horm Metab Res: 2010; 42 887 891
13. Morgan S A, Sherlock M, Gathercole L L. 11β-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes: 2009; 58 2506 2515
14. Tahrani A A, Bailey C J, Del Prato S et al. Management of type 2 diabetes: new and future developments in treatment. Lancet: 2011; 378 182 197
15. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem: 1976; 72 248 254
16. Dai C Y, Huang J F, Hsieh M Y. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. J Hepatol: 2009; 50 712 718
17. Kim-Dorner S-J, Deuster P A, Zeno S A et al. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance. Metab Clin Exp: 2009; 59 299 304
18. Zhu S K, Wang Z, Heshka S et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr: 2002; 76 743 749
19. Pi-Sunyer F X. Obesity: criteria and classification. Proc Nutr Soc: 2000; 59 505 509
20. Eriksson J, Franssila-Kallunki A, Ekstrand A. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med: 1989; 321 337 343 (Pubitemid 19190437)
21. Lillioja S, Mott D M, Spraul M. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Prima Indians. N Engl J Med: 1993; 329 1988 1992 (Pubitemid 24015042)
22. Maffei M, Halaas J, Ravussin E. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-induced subjects. Nat Med: 1995; 1 1155 1161
23. Kopelman P G, Grossman A, Lavender P et al. The cortisol response to corticotrophin-releasing factor is blunted in obesity. Clin Endocrinol (Oxf): 1988; 28 15 18 (Pubitemid 18027502)
24. Stewart P M, Boulton A, Kumar S et al. Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab: 1999; 84 1022 1027 (Pubitemid 29138237)
25. Rosmond R, Dallman M F, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab: 1998; 83 1853 1859 (Pubitemid 28496305)
26. von Geldern T W, Tu N, Kym P R et al. Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes. J Med Chem: 2004; 47 4213 4230 (Pubitemid 39056076)
27. Rask E, Olsson T, Soderberg S. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab: 2001; 86 1418 1421 (Pubitemid 32323037)
28. Rosenstock J, Banarer S, Fonseca V A. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor incb13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care: 2010; 33 1516 1522
29. Whorwood C B, Donovan S J, Flanagan D et al. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes: 2002; 51 1066 1075
30. Ishizaki H, Kariya Y. Effects of peripheral blood polymorphonuclear leukocyte function and blood components in Japanese black steers administered ACTH in a cold environment. J Vet Med Sci: 1999; 61 487 492 (Pubitemid 129586521)
31. Bonifazi M, Mencarelli M, Fedele V et al. Glucocorticoid receptor mRNA expression in peripheral blood mononuclear cells in high trained compared to low trained and untrained subjects. J Endocrinol Invest: 2009; 32 816 820
32. Yehuda R, Lowy M T, Southwick S M et al. Lymphocyte glucocorticoid receptor number in post-traumatic stress disorder. Am J Psychiatry: 1991; 148 499 504